Cancer of the Prostate: Molecular Genetics
219
Voeller, H.J., Truica, C.I., Gelmann, E.P. (1998)
α
-catenin
mutations
in
human
prostate
cancer,
Cancer Res.
58
, 2520–2523.
Wang, S.I.,
Parsons, R.,
Ittmann, M.
(1998)
Homozygous deletions of the PTEN tumor
suppressor
gene in a subset of prostate
adenocarcinomas,
Clin.
Cancer
Res.
4
,
811–815.
Watanabe, M., Imai, H., Kato, H., et al. (1996)
Microsatellite instability in latent prostate
cancers,
Int. J. Cancer
69
, 394–397.
Wertz, I.E.,
Deitch, A.D.,
Gumerlock, P.H.,
et al.
(1996)
Correlation
of
genetic
and
immunodetection
of
TP53
mutations
in
malignant and benign prostate tissues,
Hum.
Pathol.
27
, 573–580.
Whittemore, A.S. (1994) Prostate cancer,
Cancer
Surv.
19
, 309–322.
Williams, R.H.,
Stapleton, A.M.F.,
Yang, G.,
et al. (1996) Reduced levels of transforming
growth factor beta receptor type II in human
prostate
cancer:
an
immunohistochemical
study,
Clin. Cancer Res.
2
, 635–640.
Xu, J.,
Meyers, D.,
Freije, D.,
et al.
(1998)
Evidence for a prostate cancer susceptibility
locus on the X chromosome,
Nat. Genet.
20
,
175–179.
Yan, G., Fukabori, Y., Nikolaropoulos, S., et al.
(1992) Heparin-binding keratinocyte growth
factor is a candidate stromal to epithelial
andromedin,
Mol. Endocrinol.
6
, 2123–2128.
Yeh, S.,
Lin, H.K.,
Kang, H.Y.,
et al.
(1999)
From HER2/neu signal cascade to androgen
receptor and its coactivators: a novel pathway
by induction of androgen target genes through
MAP kinase in prostate cancer cells,
Proc. Natl.
Acad. Sci. U.S.A.
96
, 5458–5463.
Zhang, W.,
Kapusta, L.R.,
Slingerland, J.M.,
Klotz, L.H.
(1998)
Telomerase
activity
in
prostate
cancer,
prostatic
intraepithelial
neoplasia, and benign prostatic epithelium,
Cancer Res.
58
, 619–621.
Zhang, X.A.,
Lane, W.S.,
Charrin, S.,
Rubin-
stein, E., Liu, L. (2003) EWI2/PGRL associates
with the metastasis suppressor KAI1/CD82
and inhibits the migration of prostate cancer
cells,
Cancer Res.
63
(10), 2665–2674.
Zhang, X.H., Sakamoto, H., Takenaka, I. (1996)
Accumulation
of
p53
and
expression
of
CD44
in
human
prostatic
cancer
and
benign
prostatic
hyperplasia:
an
immunohistochemical study,
B
r
.J
.U
ro
l
.
77
,
441–444.
Zheng, D.Q., Woodard, A.S., Fornaro, M., et al.
(1999) Prostatic carcinoma cell migration via
alpha(v)beta3 integrin is modulated by a focal
adhesion kinase pathway,
Cancer Res.
59
,
1655–1664.
previous page 893 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 895 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off